These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10462610)

  • 41. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
    Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
    Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
    Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
    Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 isoforms, including the CD44 V3 variant, are expressed on endothelium, suggesting a role for CD44 in the immobilization of growth factors and the regulation of the local immune response.
    Koopman G; Taher TE; Mazzucchelli I; Keehnen RM; van der Voort R; Manten-Horst E; Ricevuti G; Pals ST; Das PK
    Biochem Biophys Res Commun; 1998 Apr; 245(1):172-6. PubMed ID: 9535803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of CD44 in human neoplastic and normal hyaline cartilage.
    Bosch PP; Stevens JW; Noonan KJ; Buckwalter JA; Midura RJ
    Iowa Orthop J; 2002; 22():47-54. PubMed ID: 12180611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Separation and characterization of epithelial cells from prostates and prostatic carcinomas: a review.
    Pretlow TG; Brattain MG; Kreisberg JI
    Cancer Treat Rep; 1977; 61(2):153-6. PubMed ID: 872127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
    Yang K; Tang Y; Habermehl GK; Iczkowski KA
    BMC Cancer; 2010 Jan; 10():16. PubMed ID: 20074368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression profile of standard and variants forms of CD44 related to prostate cancer behavior.
    Moura CM; Pontes J; Reis ST; Viana NI; Morais DR; Dip N; Katz B; Srougi M; Leite KR
    Int J Biol Markers; 2015 Feb; 30(1):e49-55. PubMed ID: 24832177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell adhesion molecule CD44: its functional roles in prostate cancer.
    Iczkowski KA
    Am J Transl Res; 2010 Sep; 3(1):1-7. PubMed ID: 21139802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical and soluble expression of CD44 in primary and metastatic human prostate cancers.
    Griebling T; Palechek P; Cohen M
    Int J Oncol; 1997 Apr; 10(4):697-702. PubMed ID: 21533433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Correlation among expression of CD44, DNA content and apoptosis in female adenocarcinoma of the lung].
    Xue X; Zhang Y; Jiang D; He Q; Cui Z; Zhou B
    Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):381-5. PubMed ID: 21126405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CD44 standard form and variant isoforms in human bone marrow stromal cells.
    Wang X; Du Z; Liu X; Song Y; Zhang G; Wang Z; Wang Q; Gao Z; Wang Y; Wang W
    Saudi Pharm J; 2017 May; 25(4):488-491. PubMed ID: 28579880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silibinin suppresses CD44 expression in prostate cancer cells.
    Handorean AM; Yang K; Robbins EW; Flaig TW; Iczkowski KA
    Am J Transl Res; 2009 Jan; 1(1):80-6. PubMed ID: 19966941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.
    Yang K; Tang Y; Iczkowski KA
    Am J Transl Res; 2010 Jan; 2(1):88-94. PubMed ID: 20182585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine.
    Sugiyama M; Woodman A; Sugino T; Crowley S; Ho K; Smith J; Matsumura Y; Tarin D
    Clin Mol Pathol; 1995 Jun; 48(3):M142-7. PubMed ID: 16695995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.